Targeting FGFR in urothelial carcinoma Published 2019-11-17 Download video MP4 360p Download video MP4 720p Recommendations 46:22 Review of the Role of Lymph Node Dissection in Urothelial Carcinoma 14:46 Excess Deaths at Night - Obstructive Sleep Apnea Explained Clearly 54:35 Ureteric Stents: Complications and Advancements 10:15 Acute Myeloid Leukemia | Clinical Presentation 47:53 The State of Benign Prostate Hyperplasia: Leading Theories and Challenges... 1:02:36 Wstań rano, zrób przedziałek i odp***** się od siebie! 18:40 Matthew Perry's death from Ketamine explained (is it safe for you?) 05:34 Cell Signaling- Tyrosine Kinase receptors 41:32 Dysfunkcyjne życie zakonnic 52:51 Prostate MRI: An Update 1:16:35 Retroperitoneal lymph node dissection for testicular cancer 18:46 Approach to the Exam for Parkinson's Disease 37:12 Sekielski o nałogach: Tomasz Piątek o wyjściu z najcięższego nałogu 52:32 Genomic Biomarkers for Improving Bladder Cancer Patient Care 47:46 Peri-Operative Pain Management 17:26 How to Thrive as A Highly Sensitive Person (HSP) 27:12 Walking on a Tightrope: Gemma's Multiple Myeloma Journey 28:56 Loneliness hurts my ME/CFS patients more than science shows - LIVE 42:46 10 Years of MRI-Targeted Biopsy: What We Have Learned, and What We Have Yet to Learn 36:59 Charting a New Course: Transforming the Transition to Adult Care Process in British Columbia Similar videos 17:27 New FDA-Approved Therapy for Targeting FGFR Alterations In Advanced Urothelial Cancer 02:59 Effectively Target FGFR with Erdafitinib for Bladder Cancer? Highlights from ASCO 2018 (BMIC-050) 05:24 Case 3: FGFR-Targeted Therapy Adverse Events in Bladder Cancer 44:45 Targeting FGFR Alterations in Cancer with a Selective FGFR Inhibitor - Dr. Randi Isaacs 04:43 Erdafitinib for FGFR-mutated urothelial carcinoma 02:29 Additional Insights: Experience with FGFR Inhibitors in Bladder Cancer 01:23 Recent advances in the use of targeted therapies for metastatic urothelial carcinoma 07:18 Case 3: Experience With FGFR-Targeted Therapies in Bladder Cancer 20:21 Targeted Therapy for the Treatment of Advanced Metastatic Urothelial Cancer YouTube 03:02 Discussion on Trial Investigating Erdafitinib in Patients With Urothelial Cancer 02:31 An update on erdafitinib for metastatic/uresectable FGFR alteration urothelial carcinoma 04:03 FGFR Inhibitors for CCA & Bladder Cancer 12:14 The latest in bladder cancer with FGFR 2 and 3 mutations 01:54 Targeted therapy effective for patients with advanced bladder cancer and specific gene mutations 20:59 New Targets for the Treatment of Urothelial Cancer 04:47 ASCO 2023 Highlights on erdafitinib in metastatic urothelial cancer with select FGFR alterations 00:24 HER2-targeting ADCs for urothelial carcinoma 02:01 FGFR Mutations 00:55 Targeted Therapy Option of Erdafitinib in Bladder Cancer #oncology #cancer #2023 More results